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I. Abstract 
Morphogens play a significant role in the modulation of cell fate and 
development and are expressed in all tissue at some point during development.  Recent 
studies suggest that expression of two morphogens, Hedgehog (Hh) and Bone 
Morphogenetic Protein (BMP), may influence immune cell development in the 
periphery which is consistent with the finding that Hh is expressed by splenic stromal 
cells.  In addition, preliminary data obtained at UEL suggest that Hh signalling may 
provide a positive signal in early peripheral B cell development in terms of activation 
and survival but may then deliver a later negative immunoregulatory signal capable of 
dampening down the immune response. This may occur as a consequence of the ability 
of Hh signalling to upregulate expression of BMP. Although Hh and BMP signalling 
have both been shown to play a role in immune cell development independently, little is 
known regarding the interplay between the two morphogens and the role this may play 
in directing an immune response to antigen.   In this study murine splenic B cells were 
cultured in the presence of a signal for B cell activation (anti-IgM and anti-CD40) 
together with recombinant Sonic Hedgehog protein (rShh) and a BMP inhibitor, 
Noggin.  These experiments were designed in order to elucidate whether it is necessary 
for Hh signalling to upregulate the expression of BMP for an effective B cell response 
to take place.  We observed that expression of both Hh and BMP is required for 
efficient activation and survival of B cells at 18 hours post stimulus whilst expression of 
BMP plays a more dominant role in the later stages of B cell development.  Abrogation 
of BMP signalling led to a significant skewing in the development of certain B cell 
subsets. Further analysis revealed a potential role for BMP-2 in particular during splenic 
B cell development, expression of which was significantly upregulated in the presence 
of exogenous Hh.  Overall, our findings suggest that there is indeed an interplay 
between Hh and BMP signalling in driving appropriate B cell development. 
III 
 
II. Acknowledgements 
Firstly, I would like to offer my sincerest thanks to my Director of Studies, 
Susan Outram, who has been encouraging and supportive throughout the entire MRes 
process. 
Secondly, to Cynthia Umukuro who has, with patience and kindness, answered 
all of my questions and always been willing to demonstrate laboratory techniques. 
Thirdly, to David Guiliano, who has always made time for me and supported me 
as part of my MRes supervisory team. 
Lastly, to my wonderful grandad, thank you for giving me absolutely 
everything, believing in me when others did not and encouraging me to the end. This is 
for you.  
 
 
 
 
 
 
 
 
 
 
 
IV 
 
Table of Contents 
I. Abstract ........................................................................................................... II 
II. Acknowledgements ..................................................................................... III 
Table of Contents ............................................................................................. IV 
IV. List of Tables .............................................................................................. VI 
List of Figures ................................................................................................... VI 
V. Abbreviations .............................................................................................. VII 
1.  Introduction ............................................................................................... - 1 - 
1.1. The Immune Response ......................................................................... - 1 - 
1.1.1. B cell Development ........................................................................ - 1 - 
1.1.2. Immune Resolution ......................................................................... - 5 - 
1.2. Man versus Mice .................................................................................. - 6 - 
1.3. Morphogens .......................................................................................... - 6 - 
1.3.1. Morphogen Dynamics in Developing Cells .................................... - 6 - 
1.3.2 The Origins of Hedgehog Proteins .................................................. - 8 - 
1.3.3. BMP Signalling ............................................................................. - 11 - 
   1.3.4 Morphogen signalling in peripheral B cell development………….- 13 - 
1.4. Aims .................................................................................................... - 13 - 
2.   Methods and Materials .......................................................................... - 15 - 
2.1. Animal Experimentation ..................................................................... - 15 - 
2.2. Cell culture .......................................................................................... - 15 - 
2.3 Isolation of B-cells using Negative Selection ....................................... - 16 - 
2.4 Analysis of cell surface markers using Flow Cytometry ...................... - 16 - 
2.5 Enzyme Linked Immunosorbent Assay (ELISA) ................................... - 18 - 
2.6 Gene Expression Analysis .................................................................... - 19 - 
2.6.1 RNA Isolation and cDNA Synthesis ............................................... - 19 - 
2.6.2 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) . - 19 - 
2.7 Statistical Data Analysis ...................................................................... - 20 - 
3. Results ....................................................................................................... - 21 - 
3.1 The role of Hh and BMP signalling within a heterogeneous splenic 
population .............................................................................................................. - 21 - 
V 
 
3.2 The effects mediated by Hh and BMP signalling are intrinsic to B cells- 29 
- 
3.3 BMP signalling may drive the development of a Follicular B cell subset ... - 
34 - 
3.4 Dampening down of the immune response is a result of BMP expression. . - 
37 - 
3.5. BMPR1α knockout mice display a skewed phenotype ........................ - 44 - 
4. Discussion .................................................................................................. - 51 - 
4.1. Hh and BMP signalling regulate early activation and survival of 
peripheral B cells ................................................................................................... - 52 - 
4.2. Hh and BMP synergistically induce T2 to follicular B cell transition - 53 - 
4.3. BMP signalling dampens down later immune responses .................... - 54 - 
4.4. BMPR1a knockout mice display impaired B cell development ........... - 56 - 
4.5. Hh and BMP signalling interact to induce BMP-2 expression ........... - 57 - 
4.6. Future work ......................................................................................... - 60 - 
5. Concluding remarks ................................................................................ - 60 - 
6. References ................................................................................................. - 62 - 
 
 
 
 
 
 
 
 
 
VI 
 
IV. List of Tables 
Table 2.1 Table of Markers…………………………………………………........  17 
 
List of Figures 
Figure 1.1 B cell development……………………………………….................. 2 
Figure 1.2 Hedgehog Signalling……………………………………………....... 10 
Figure 1.3 BMP Signalling……………………………………………………... 12 
Figure 3.1 Gating strategy for B220+ cells……………………………………... 21 
Figure 3.2 CD23 and CD25 expression at 18 hours in BALB/c 
mice……………. 22 
Figure 3.3 CD23 and CD25 expression at 40 hours in BALB/c 
mice……………. 25 
Figure 3.4 Annexin V binding at 18 and 40 hours in BALB/c 
mice……………… 28 
Figure 3.5 CD23 and CD25 expression at 18 hours in purified C57BL/6 B cells 31 
Figure 3.6 CD80 at 18 hours in C57BL/6 male mice………………………....... 33 
Figure 3.7 IgD and CD23 expression at 18 hours in C57BL/6 male mice........... 34 
Figure 3.8 IgM in subsets at 18 hours in C57BL/6 male mice……………......... 36 
Figure 3.9 IgD and CD23 expression at 40 hours in C57BL/6 male mice........... 38 
Figure 3.10 IgM in subsets at 40 hours in C57BL/6 male mice……………......... 39 
Figure 3.11 CD23 and CD25 expression at 40 hours in purified C57BL/6 B cells 40 
Figure 3.12 CD80 at 40 hours in C57BL/6 male mice …………………….......... 41 
Figure 3.13 Annexin V binding at 18 and 40 hours in C57BL/6 male mice…….. 43 
Figure 3.14 B cell subsets in BMPR1α KO and BMPR1α WT mice 
……………... 45 
Figure 3.15 IgD and CD23 expression at 18 hours in BMPR1α KO and WT 
mice 47 
Figure 3.16 Annexin V binding at 18 and 40 hours in BMPR1α KO and WT 
mice 48 
Figure 3.17 IL-10 secretion at 18 hours in BMPR1α KO and WT 
mice…………... 49 
Figure 3.18 BMP-2 expression at 18 hours in BMPR1α KO and WT 
mice………. 50 
Figure 4.1  TD B cell development in response to Hh signalling……………….. 59 
VII 
 
V. Abbreviations 
Μg Micrograms 
Μl Microlitres 
-/- Knockout 
+/+ 
APC 
BCR 
Wildtype 
Allophycocyanin 
B Cell Receptor 
BMP 
Btk 
Bone Morphogenetic Protein 
Bruton’s Tyrosine Kinase 
CD Cluster of Differentiation 
cDNA Complementary Deoxyribonucleic Acid 
dNTP’s Deoxynucleotide Triphosphate 
DNA Deoxyribonucleic Acid 
ECM Extracellular Matrix 
FCS Foetal Calf Serum 
FITC Fluorescein Isothiocyanate 
KO Knockout 
Mg Milligrams 
Ml Millilitres 
M Moles 
mRNA Messenger Ribonucleic Acid 
MZ 
Ng 
Marginal Zone 
Noggin 
PBS Phosphate Buffered Solution 
PCR Polymerase Chain Reaction 
PE PhycoErythrin 
PRR Pattern Recognition Receptor 
rSHh Recombinant Sonic Hedgehog 
RT-PCR Real-time Polymerase Chain Reaction 
SD 
TD 
Standard Deviation 
T cell-dependent 
TGF-B Transforming Growth Factor Beta 
WT Wildtype 
2-BME 2-Beta Mercaptoethanol 
VIII 
 
- 1 - 
 
1.  Introduction 
1.1. The Immune Response 
1.1.1. B cell Development 
B cells undergo early development within the unique microenvironment of the 
bone marrow, originating from progenitor cells known as haematopoietic stem cells 
(HSC) (Murphy, 2012). In a structured sequence of events regulated by the surrounding 
scaffold of stromal cells and the factors secreted by stromal cells, a series of Ig receptor 
editing phases take place culminating in the expression of a mature antigen receptor on 
the B cell surface (BCR). These processes involve the induction of V(D)J 
rearrangement and somatic hypermutation, according to the nature and strength of the 
signal.  Thus, B cells develop, guided by the expression of, amongst other factors, 
RAG-1 and 2, from stem cells through to pro-B cells, pre-B cells and, finally, mature B 
cells in the bone marrow (Murphy, 2012). Once mature, the B cell may exit the bone 
marrow and move to the peripheral lymphoid tissue as transitional T1 B cells where 
they undergo further differentiation in response to their specific antigen. 
Peripheral B cells may fall in to three major groups: B1 cells, B2 cells and 
regulatory B cells (Bregs).  The latter cell has been only recently identified and is 
known to have the ability to dampen down immune responses.   B1 cells are mostly 
found within the peritoneal spaces and within the gastro-intestinal tract, B2 cells are 
predominantly found within the spleen and lymph node whilst a specific location for 
Bregs has yet to be fully elucidated.  As previously mentioned, B cells within the 
periphery originate from a transitional subset (T1) and the strength and type of signal 
received will determine cell fate.  T1 cells are an immature subset of B cells which may 
mature to acquire T2 status or, upon Toll-like receptor (TLR)  stimulation, develop into 
marginal zone B cells (MZB) acting as innate-type cells (Guerrier et al., 2012) (Figure 
1.1).  Numerous studies have elucidated that T1 cells readily undergo apoptosis in 
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response to a tonic signal through the BCR whilst a strong signal will lead to 
polarisation of a T1 cell to become a T2 cell (Pillai and Cariappa., 2009).  T2 cells are a 
highly diverse group of cells which have the capacity to further polarise into marginal 
zone precursors (MZP), follicular type I or follicular type II cells.  Importantly, T2 cells 
cannot be activated by TLR activation alone; at this stage in development, BCR 
stimulation and co-stimulation must also take place in order to elicit an efficient 
immune response. 
 
 
 
 
 
 
 
 
 
 
 
 
Crucially Loder et al (1999), using mice lacking the Ig-α cytoplasmic tail 
required for BCR signalling, noticed that the T2 and mature B cell repertoire had failed 
to develop whilst the T1 population remained present at normal levels of around 20 per 
cent of splenic B cells indicating that signalling through the BCR is required for the 
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transition from T1 to T2 B cell.  In addition, mice lacking the gene for Lyn, a src family 
kinase also required for appropriate signalling through the BCR, had normal numbers of 
pro-, pre- and immature B cells in the bone marrow in contrast to mature B cells which 
had reduced 10-20 fold (Allman et al., 2001).  Furthermore, an inverse relationship 
between the strength of BCR signalling and marginal zone cell development was noted 
by Cariappa et al in 2001.  Marginal zone B cells respond rapidly, to stimulation via 
innate immune receptors such as TLR indicating that their purpose is fit for the location 
in which they reside. Marginal zone B cells are the first point of contact for many 
blood-borne antigens following entry in to the body therefore it is essential they have 
the ability to develop and proliferate in direct response to stimulation through the 
pattern recognition receptor (PRR).  Thus far, MZB cells have been assumed to be 
limited in their abilities to migrate into the primary lymphoid follicles, however, a 
recent study (Ferguson and Corley., 2005) discovered that marginal zone B cells, in 
fact, traffic antigens across the mantle zone, into the follicles to stimulate follicular B 
cell and T cell help. 
Naïve mature B cells enter the peripheral circulation, recirculate through the 
lymphoid organs and migrate to the spleen, residing in primary follicles until an antigen 
is encountered.  Upon BCR cross-linkage and T-cell co-stimulation via CD40, highly 
specialised germinal centres are formed providing the B-cells with a site where the 
cytokines and growth factors required for clonal expansion and differentiation are 
expressed.   Within the germinal centres B-cells become activated undergoing class 
switching mediated by activation-induced cytidine deaminase (AID) and affinity 
maturation - a process whereby the production of low affinity antibodies is replaced by 
the production of specific high affinity antibodies that will clear an invading infection 
more efficiently.   Activated B-cells have the propensity to form short-lived plasma 
cells, long-lived plasma cells (LLPC), memory cells or regulatory B-cells; the latter 
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being a critical factor in abrogating the immune response.  Current research has shown 
that B cells expressing a high affinity BCR prior to GC formation will go on to act as 
short term plasma cells whilst those with a lower affinity are required to undergo class-
switching in order to increase their affinity for an antigen (Cariappa and Pillai., 2007). 
In addition to phenotypic changes during B cell development, a number of 
transcriptional modifications occur characterised by the expression of a number of 
transcription factors such as Pax-5, BAFF and BLIMP-1.  Expression of PAX-5 is 
associated with immature B cell development and ensures a state of self-renewal.  
Additionally, Debnath et al (2008) noted that loss of PAX-5 correlates with a decrease 
in expression of CD21 and CD23 indicating that PAX-5 is a redundant transcription 
factor in memory and plasma cell differentiation.  BAFF is a survival factor, expression 
of which is important in the transitional period between the naïve T1 B cells developing 
into activated follicular B cells.  BAFF expression itself reduces expression of the pro-
apoptotic factor, Bim via an NF-kB dependent pathway leading to increased cell 
survival.  BLIMP-1 is a transcription factor with repressor activity, typically repressing 
PAX-5 expression.  Repression of PAX-5 leads to the expression of, an endonuclease 
IRE-1, which subsequently splices a 26-nucleotide intron from an inactive isoform of 
XBP-1, an mRNA present in all cells, subsequently leaving an active form.  Expression 
of XBP-1 is associated with the unfolded protein response and regulates levels of ER 
stress during increased levels of protein folding such as that during antibody production, 
thus is associated with plasma cell development.  Interestingly, XBP-1 has also been 
shown to play a role in the regulation of IL-6 expression; a cytokine also involved in 
plasma cell differentiation (Iwakoshi et al., 2003).  Presently, there is an absence of 
knowledge regarding the role of specific transcription factors associated with memory 
cell development and function although a study by Tomayko et al in 2009 suggested 
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that memory cells have characteristics in common with naive B cells and this is likely to 
be a result of the need for longevity and self-renewal. 
1.1.2. Immune Resolution 
Resolution of the adaptive immune response following immune insult is a 
critical stage in restoration of immune homeostasis.  The numbers of effector cells and 
secretion of their associated cytokines are downregulated, in order to prevent aberrant or 
collateral damage to the host, as inefficient termination is a well-documented cause of 
auto-immune and auto-inflammatory disorders.  Termed the resolution phase, numerous 
processes exist to ensure that basal levels of immunity are restored in a timely manner: 
secretion of suppressive cytokines; expression of inhibitory ligands leading to anergy 
and induction of apoptosis; and polarisation of regulatory T and B cell subsets.  To date, 
regulatory subsets of T cells, dendritic cells and macrophages have been well 
characterised.  However, the characterisation of B cells possessing regulatory 
characteristics, such as the expression of IL-10, remain largely elusive despite a 
significant amount of research within the area.  Phenotypically, B10 cells or Bregs, as 
they are more commonly known due to the fact that they all secret IL-10, appear to lack 
distinct characteristics. However, a small number of studies using murine models of 
lupus suggest that regulatory B cells have features which mimic naive cells and are 
CD24+ CD1d+CD19+ (Blair et al., 2010).    A significant proportion of research suggests 
that IL-10 is the factor responsible for driving immune resolution. 
IL-10 is a 18.5kDa protein which acts as a pleotrophic cytokine involved in the 
regulation of immune reponses.  Historically, IL-10 has been associated with the 
suppression and inhibition of the immune response and a number of inhibitory 
mechanisms have been described including:  inhibition of pro-inflammatory cytokine 
production, downregulation of co-stimulatory ligands, such as the B7 family, and the 
development of antibody-forming B cells (Saraiva and O’Garra., 2010). Nonetheless, in 
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recent times a paradoxical role as a pro-inflammatory and survival factor has been 
revealed particularly in autoimmune diseases such as Systemic Lupus Erythromatosus 
(Park et al., 1998).  The exact molecular mechanisms of IL-10 remain controversial 
however many studies agree IL-10 signalling activates STAT3 and immunomodulates 
predominantly through an NF-κB-dependent manner (Niemand et al., 2003) 
1.2. Man versus Mice 
Currently, a noteworthy amount of research has focused on B cell development 
within disease models in mice and in humans, however, specific B cell-mediated 
immune responses in normal healthy mice remain elusive.  There are notable 
differences between markers associated with human and mouse B cells such as the 
variance in memory cell markers CD27 in humans, and CD80 in mice (Tomayko et al., 
2008; Wang et al., 2006).    In addition, variance between gender and strain of mouse 
are likely to influence results in studies utilising murine disease models.  Exposing 
precise differences in specific models will ensure that research characterising immune 
diseases, such as Lupus, in mice is consistent and reliable. With this in mind, we will 
examine the role of morphogens on T cell dependent (TD) B cell development in 
BALB/c female and C57BL/6 male mice and elucidate any notable differences. 
1.3. Morphogens 
1.3.1. Morphogen Dynamics in Developing Cells 
Morphogens are evolutionarily conserved extracellular cell surface or secreted 
proteins displaying high pleotropic tendencies and governing a multitude of 
developmental processes including cell fate, patterning and organogenesis in many 
vertebrates.  Unsurprisingly, expression of many morphogens has been shown to be 
constitutive during embryogenesis whilst tightly regulated thereafter by the presence of 
numerous regulatory proteins dependant on the specific type.  Morphogens transduce 
signals by varying mechanisms which include: secretion from a local source such as 
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cells of the extracellular matrix (ECM), or by diffusion according to Fick’s law and 
ligand-internalisation via cognate receptors (Tanaka et al., 1997).  Consequently, a 
dynamic long-range concentration gradient capable of influencing cell fate is formed; 
the stability of a gradient is essentially reliant on a steady-state arrangement of synthesis 
and decay at its source (Eldar et al., 2003) and receptor kinetics (Porter et al., 1996).  
The formation of a ‘threshold’ in which cells will or will not respond forms the basis of 
morphogen signalling. Subsequent target cell responses are dependent on their intricate 
spatial and temporal arrangement within a concentration gradient and recent studies 
have shown that stochastic noise within gradients may cause disease (Karim et al., 
2012).   Essentially, morphogens are enigmatic entities which appear to exert effects in 
a context-dependent manner and disruptions within the complex communication 
network of morphogens is widely documented to cause severe developmental defects.  
Studies investigating the role that morphogens play in the development and 
maintenance of B-cell homeostasis has, thus far, been largely empirical and more 
research is required to elucidate the part that such disruptions may play in immune 
disorders. Systemic Lupus Erythematosus, an autoimmune disease characterised by 
massive infiltrates of inflammatory mediators, has been shown to be governed by 
plasma cells which recognise and respond to auto-antigens such as nucleic acids (Lui et 
al., 2011; Minowa et al., 2011). Multiple Myeloma, a plasma cell neoplasm whereby 
‘false’ antibodies are synthesised leads to severe immunodeficiency and immune 
complex deposits within the kidney which may cause acute renal failure.  Interestingly 
Hedgehog (Hh) signalling is often found to be dysregulated in patients suffering from 
multiple myelomas. Therefore, specific mechanisms involved in the development of B 
cells within the periphery need exposing in order to understand immune diseases such 
as those mentioned.  Within the last decade, morphogens such as Hh and Bone 
Morphogenetic Protein (BMP) have been found to play a role in many different aspects 
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of cellular development and a novel role for morphogens in self-renewing tissues has 
been revealed.  Furthermore, research has revealed the possibility of synergism between 
the two morphogens as a consequence of signalling cross-talk (Bitgood and McMahon, 
1995; Guo and Wang., 2009 and Reichert et al., 2013); thus the role of morphogens in 
peripheral immune cell development must be explicated. The various components of the 
Hh signalling pathway have been detected within both the Thymic (Outram et al 2000, 
Sacedon et al., 2003) and Splenic (Sacedon et al., 2005) environment. A significant 
proportion of research has already shown that Hedgehog proteins influence central and 
peripheral T-cell (Sacedon et al., 2003, Outram et al., 2009) and that aberrant hedgehog 
signalling may lead to various haematopoietic neoplastic disorders such as Lymphoma 
and Multiple Myeloma (Hegde et al., 2008; Irvine and Copland., 2012).  Similarly, 
BMPs are thought to play a role in the development of many haematopoietic cells and 
Sacedon et al (2005) revealed that within the stromal niche, follicular dendritic cells 
within the spleen may express such morphogens.  BMP, historically, has been 
associated with regulatory/inhibitory functions such as decreased proliferation and 
increasing cell death and, in recent years, been shown to negatively regulate the 
hedgehog signalling pathway as previously documented (Kersten et al., 2005; Seki and 
Hata., 2004). Furthermore, BMP 6 has been shown by Kersten et al, in 2005, to induce 
the expression of the Inhibitor of Differentiation family of proteins in B cells leading to 
the abrogation of peripheral B cell development.  Nevertheless, a recent paper revealed 
a more complex role for BMP in the development of immune cells in regards to 
activation and survival (Martinez et al., 2015).   
1.3.2 The Origins of Hedgehog Proteins 
Hedgehog protein is a widely studied morphogen initially discovered in the fruit 
fly Drosophilia melanogaster whereby genetic mutational analysis of the hedgehog 
gene led to formation of a spiky ‘sonic hedgehog’ appearance in the progeny (Nusslein-
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Vilhard and Wieschaus, 1980).  Within mammals, there are three well established 
homologues of Hedgehog proteins – Desert, Indian and Sonic which are structurally 
conserved, however, a single variation in amino acid sequence was noted in 1995 by 
Kumar et al, indicating that their affinity for specific Hh signalling receptors could vary 
to some extent and may also be responsible for variability of Hh expression in specific 
tissue types.  Hedgehog plays a critical role in embryonic development with the 
differential expression of the Hh gene governing cell fate, patterning and organogenesis.  
Hedgehog proteins are synthesised as precursor proteins, approximately 45 kDa, which 
are subject to internal cleavage by the C-terminus leaving the 20 kDa N-terminus which 
has previously been documented to contain all signalling capabilities (Porter et al., 
1996).  Previous work has suggested that nucleophilic attack by the C-terminus 
(Cysteine 258 – Asparagine 471) leads to the generation of a thiol group between 
Glycine 257 and Cysteine 258 which is subsequently modified by the addition of a 
cholesterol moiety (Tanaka et al., 1997).  The modification leads to association of the 
Hh-N-terminus with the cell membrane. Furthermore, Porter et al., 1996 proposed that 
autolytic processing acts as a regulatory mechanism for controlling the spatial 
arrangement of Hh protein thus influencing gradient formation. 
All Hh proteins are thought to signal through an identical canonical pathway 
whereby Patched, a twelve-pass transmembrane receptor, is the ligand receptor and 
Smoothened is the seven transmembrane signal transducer of Hh signalling.  In the 
absence of a Hh ligand, the pathway is typically inhibited; Patched inhibits Smoothened 
signalling in to the cell, whilst in the presence of the Hh ligand, Smoothened 
translocates to the membrane leading to constitutive signal transduction. This signalling 
pathway culminates in the nucleus in the activation of the Gli family of transcription 
factors (Dorsam and Gutkind., 2007).  The cumulative level of Gli within the nucleus 
and the relative ratios of Gli proteins to one another determines the expression of a 
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number of target genes involved in many different processes including regulating the 
cell cycle such as the anti-apoptotic factor BCL2 and, significantly, BMP (Katoh and 
Katoh, 2009).  Gli transcription factors may be activatory or inhibitory in nature and 
their subsequent actions depends largely on a threshold system (Figure 1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.  Hedgehog Signalling Pathway. 
Schematic representing mechanisms of Hh signalling.  In the absence of a Hh ligand, 
Patched binds to Smoothened inhibiting signal transduction.  When a Hh ligand is 
present, Patched release Smoothened allowing a signal to transduce into the cell.  Hh 
signalling leads to the activation of the Gli family of transcription factors. (Crompton 
et al., 2007) 
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1.3.3. BMP Signalling 
Bone Morphogenetic Proteins are evolutionarily conserved proteins originating 
from the TGF-β family. BMP’s play a significant role in organogenesis, osteogenesis 
and are secreted by local cells within the bone marrow microenvironment, in particular, 
stromal cells. BMPs, like many morphogens, are highly complex pleotropic molecules, 
expressed differentially in almost all tissue types.  Genetic abnormalities within BMP 
genes and the associated regulatory elements cause widespread life-limiting diseases 
such as pulmonary hypertension (Newman et al., 2001) and fibrodysplasia ossificans 
progressiva (Kaplan et al., 2001). 
A significant role for BMP in the development of haematopoietic cells has 
recently been described.  To date there are twenty known homologues of mammalian 
BMPs of which BMP 2, 4, 6 and 7 have been the most extensively studied in immune 
cells (Huse et al., 2011; Kersten et al., 2005).  All are synthesised as an inactive 
precursor protein subsequently cleaved by furin, an endopeptidase, leaving the active C-
terminal signalling protein.  Active BMP’s are secreted into the extracellular matrix 
where they go on to form homo/hetero-tetramers with other BMP’s (Cui et al., 2001).  
BMP 2 has been shown to hetero-dimerise with both BMP 4 and 6 leading to 
differential regulation of downstream target gene expression.  BMP’s transduce signals 
through two receptor types: type I and type II; both serine/threonine receptors in which 
both components are required for effective signalling.  Upon binding, the type II 
receptor forms a hetero-tetramer with type I receptors and phosphorylates the Receptor-
activated Smads (R-Smads), 1, 5 and 8.  Phosphorylation of the type I receptor leads to 
recruitment of a common-mediator Smad (Co-Smad/Smad4) which leads to formation 
of a signalling complex (Figure 1.3).  This complex traverses the nuclear membrane 
leading to the transcription of a number of BMP target genes.   BMP signalling is 
unique from TGFβ in that different combinations of Smads undergo phosphorylation. 
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Interestingly, a number of papers have documented that the Indian hedgehog gene is 
likely to be a target of BMP signalling indicating that hedgehog and BMP may act 
concurrently to regulate cell development in an autocrine manner (Ditzel, 2011).  More 
recently, BMP gradient formation has been shown to play a role in cell migration and 
trafficking.  The regulation of BMP is a complex process involving various molecules 
which may agonise or antagonise BMP expression dependant on the context in which 
BMP is present. Chordin, Twisted Gastrulation, Gremlin and Noggin are all complex 
regulators of BMP.  Noggin is a potent BMP antagonist which inhibits the molecular 
interfaces of the epitopes for both BMPR I and II to prevent ligand binding (Groppe et 
al., 2003). 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. BMP Signalling Pathway. 
Schematic representing BMP signal pathway.  BMPs signal through mainly through 
BMPRI and BMPRII leading to recruitment of the Smad family of proteins. Smad 
proteins form a complex which tranverses the nuclear membrane and leads to 
transcription of target genes (Shore and Kaplan., 2010) 
 
- 13 - 
 
1.3.4 Morphogen signalling in peripheral B cell development 
Recently, a small number of studies have suggested that Hh and BMP may be 
key mediators of peripheral B cell development.  Sacedon et al (2005) labelled spleen 
tissue sections using both B220 and Shh to determine whether Shh proteins are 
expressed by B cells.  Interestingly, after overlapping stained sections they found that 
germinal centre B cells themselves are not capable of expressing Hh proteins, however, 
follicular dendritic cells displayed a capacity for Hh expression.  Furthermore, Hh 
protein expression was minimal within primary follicles suggesting that Hh may be 
upregulated upon BCR stimulation.  Consequently, this implies that Hh may be 
essential in directing a B cell mediated immune response and, additionally, that Hh 
responsive cells do not necessarily express Hh. Moreover Huse et al, in 2011, noted that 
BMP abrogated IgA, IgG and IgM secretion in human peripheral B cells, however, the 
effects of BMP’s were highly differential; BMP 6 abrogated plasma cell differentiation 
whilst BMP 7 inhibited Ig production significantly.  In addition to this, Noggin, a BMP 
specific inhibitor, inhibited BMP 2, 4 and 7 reversing the effects previously observed.  
Interestingly, BMP 6 was found not to be inhibited by the addition of Noggin 
suggesting that the inhibitor may have widely varying affinities for the BMP family of 
proteins.  Finally, BMP – 6 has been shown to inhibit proliferation in  human naïve and 
memory B cells, and induce apoptosis in memory B cells alone by induction of Smad 1, 
5 and 8 phosphorylation and upregulation of  the inhibitor of differentiation 1 (ID1) 
protein (Kersten et al., 2005). 
 
1.4. Aims 
The paucity of research focussed on the role of morphogens in peripheral B-cell 
development and the simultaneous effects on B cell plasticity means that this area of 
research remains largely uncharacterised.  Preliminary data from UEL (Umukoro et al, 
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unpublished) suggests that, following activation of B cells in culture using a stimulus 
that mimics encounter with antigen, at 18 hours post-stimulus, hedgehog provides a 
positive signal for differentiation and survival in B-cells with an increase in expression 
of surface markers associated with activation together with an increase in 
immunoglobulin secretion, however, this signal appears to be abrogated at 40 hours 
with a reduction in immunoglobulin secretion and an increase in cell death.  It is 
hypothesised that this negative signal may be due to the upregulation of expression of 
the Hh target gene, BMP, thus, in addition to BMP being a target of hedgehog, BMP 
may well be a negative regulator of the B-cell immune response. 
Specific aims 
 To elucidate whether preliminary data (Ukumoro, 2012) suggesting that, 
an early survival signal at 18 hours post-stimulus delivered by Hh also 
provides a negative inhibitory signal at 40 hours post-stimulus, is 
affected by the addition of a BMP-specific inhibitor, Noggin.  To 
characterise the B cell repertoire phenotypically in response to both 
morphogens thus revealing the role of Hh and BMP in skewing the 
direction of the B cell immune response. 
 To determine whether the response of B cells to Hh signalling, observed 
within a mixed splenocyte population, are maintained in a purified B cell 
population thus indicating that these effects are intrinsic to B cells. 
 
 
 
 
- 15 - 
 
 
2.   Methods and Materials 
2.1. Animal Experimentation 
Wild type BALB/c female and C57Bl/6 male mice were purchased from Harlan 
Laboratories UK, maintained at the animal facility in University House building located 
at the Stratford campus and allowed access to food and water ad libitum in line with the 
animals (scientific procedures) act 1986.  Splenectomies were performed between 4 – 8 
weeks old. 
BMPR1α KO and BMPR1α WT mice were bred and maintained within the 
animal facility at the Institute of Child Health, University College London.  BMPR1α 
floxed alleles from a transgenic mouse line and Cre recombinase, under the Vav 
promoter, from an additional transgenic line were crossed in order to ensure that the 
BMPR1α gene would be knocked out exclusively in haemopoietic cells.  BMPR1α KO 
and BMPR1α mice were used in collaboration with Professor Tessa Crompton at 
ICH/UCL. 
2.2. Cell culture 
Following dissection, spleens were homogenised in 10ml AIM-V (Life 
Technologies), using frosted glass slides, to obtain a single cell suspension.  Cells were 
seeded at a density of 2.5 – 3.5 x 106 per 200μls and cultured in AIM-V medium in 96 – 
well flat – bottomed treated plates at 37°C with 5% CO2. 2-β-mercaptoethanol was 
added to AIM-V prior to cell culture to maximise lymphocyte growth and reduce 
reactive oxygen species.  Activation stimuli anti-F(ab’)2 IgM and anti-CD40 
(ebioscience) were added at a final concentration of 5μg/μl to mimic an in vivo immune 
response.  Recombinant Sonic Hedgehog Protein (ebioscience) was added to all wells 
excluding unstimulated, stimulated control and stimulated Noggin (Ng).  Increasing 
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concentrations of rSHh were used: 0.005μg/ml and 0.05μg/ml to observe the effects of a 
concentration gradient on surrounding cells.  Recombinant Noggin (ebioscience), a 
BMP inhibitor, was added at a final concentration of 10μg/ml. 
The purpose of the activation stimuli is to mimic an in vivo immune response to 
antigen; stimulation of IgM mimics the signal delivered to the BCR by antigen and anti-
CD40 mimics the signal provided by a helper T cell. 
2.3 Isolation of B-cells using Negative Selection 
B-cells were be isolated from the splenocyte population using the EasySep 
negative magnetic bead selection kit (Stemcell Technologies) and and subject to 
previous cell culture conditions in order to elucidate whether morphogen responsiveness 
is intrinsic to B-cells as opposed to alternate cells contained within the splenocyte 
population.  Briefly, cells were centrifuged, supernatant removed and pellet resuspended 
in 2ml 2% Foetal Calf Serum (FCS)/Phosphate Buffered Solution (PBS).  Cells were 
counted using a haemocytometer and, dependent on cell count, between 50-100μl of rat 
serum added.  Following this, 50μl of a B cell isolation cocktail was added and 
incubated at 4C for 15 minutes.  Biotin was added at 50μl/ml and incubated again for 15 
minutes at 4C.  100μl of magnetic beads were added after homogenisation and 
incubated for 5 minutes at room temperature. Finally, tubes containing samples were 
inserted into the Easysep magnet and incubated at room temperature for 5 minutes, after 
which, cells were poured off into a new sterile tube.  Cells were counted and 
resuspended to yield a final cell count of 3.5x106/ml.  B cell purity ranged between 93% 
and 99% when assessed by flow cytometry.  
2.4 Analysis of cell surface markers using Flow Cytometry 
At 18 and 40 hours post-stimulus cells were stained using fluorescence-
conjugated antibodies to specific cell markers and analysed using flow cytometry in 
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order to determine cells types and the status of cell survival.  Briefly, FC receptors were 
blocked using anti CD16/32, prior to staining, to prevent non-specific binding.  10ul of 
CD16/32 was added to 190μl PBS supplemented with FCS at a final concentration of 
2%.  Cells were incubated on ice for 10 minutes.  Staining using fluorescence-
conjugated antibodies to B220, CD23, CD25, CD80, CD138, IgD, IgM and Annexin-V 
followed this.  Antibodies were diluted 1:100 using 2% FCS/PBS, and incubated on ice 
for 60 minutes, as this had previously been optimised and considered the most efficient 
staining protocol.  Mixed splenocytes were gated on B220 to ensure the population 
majority consisted of B-cells. All antibodies were purchased from eBioscience 
excluding CD138 which was purchased from BD Pharmingen. 
Figure 1.1 Table of CD Markers.  
. 
 
 
 
 
 
 
 
 
 
 
CD Marker Function Antibody Supplier 
B220 Murine CD45 receptor Tri-colour Ebioscience 
CD23 Low affinity IgE receptor.  
Expressed on naïve and 
activated B cells 
FITC Ebioscience 
CD25 IL-2α receptor component.  
Expressed on mature, 
differentiating B cells  
PE Ebioscience 
CD80 Co-stimulatory ligand 
expressed on germinal centre 
and memory B cells. 
APC Ebioscience 
CD138/Synedan 
1 
Adhesion molecule expressed 
on plasmablasts. 
APC BD 
Pharmingen 
IgD Immunoglobulin expressed on 
immature and naïve B cells 
FITC Ebioscience 
IgM Immunoglobulin differentially 
expressed on immature and 
mature B cells 
PE Ebioscience 
CD23 As before  Tri – 
colour 
Ebioscience 
Annexin V Binds to phosphotidylserine 
on cells undergoing apoptosis 
FITC Ebioscience 
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2.5 Enzyme Linked Immunosorbent Assay (ELISA) 
Using supernatants from the cells at both 18 and 40 hours, an IL-10 ready-SET-
go ELISA (eBioscience) was carried out in order to detect the secretion of IL-10, thus 
indicating which subset of B-cells had developed under the influence of Hh and BMP 
signalling. Briefly, 40μl of capture antibody was added to 10mls 1X coating buffer and 
100μls pipetted into each well of a Corning Costar ELISA plate.  Plates were sealed and 
incubated overnight at 4°C.  After 24 hours, wells were aspirated and washed four times 
using 250μls ELISA wash buffer (1XPBS + 250μl 20% Tween) in each well.  Plates 
were left for 1 minute between each wash.  Following this, wells were blocked using 
200μls of a 1:5 dilution of ELISA diluent, sealed and incubated for 1 hour at room 
temperature.  Whilst plates were incubating, 20μls of IL-10 standard was added to 5mls 
diluent to make a stock solution of 4ng/ml.  A series of standards were prepared by 
adding 400μls diluent each to 4 eppendorfs then 400μls of stock solution added to the 
first Eppendorf.  Subsequent serial dilutions ensued in order to create a calibration 
curve.  BMPR1α KO and BMPR1α WT samples were diluted 1:10 to allow for accurate 
extrapolation of data.  100μls of each standard or sample were added to wells in 
triplicate, sealed and incubated overnight at 4°C.  Finally, wells were washed 5 times 
using ELISA wash, 100μls of detection antibody added to wells and incubated at room 
temperature for 1 hour.  After washing five times, 100μls HRP was added and incubated 
at room temperature for 30 minutes.  Washing was performed seven times with 1-2 
minutes between each wash.  100μls of 1X TMB solution added to wells and incubated 
for 15 minutes at room temperature.  50μls of 1M H2SO4 was utilised as stop solution 
and absorbance measured at both 450nM and 540nM. 
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2.6 Gene Expression Analysis 
2.6.1 RNA Isolation and cDNA Synthesis 
RNA was isolated from B cells using an RNA isolation kit (Ambion) with the 
addition of 2-βME to lysis buffer, as stated in the protocol provided.  Briefly, cells were 
centrifuged for 10 minutes at 12,000g at supernatant removed and stored at 4°C for later 
ELISA analysis.  Pellets were re-suspended in 300μls of lysis buffer and vortexed until 
pellets were homogenised.  RNA was isolated from cells using an RNA isolation kit 
with an additional DNase1 stage to remove genomic DNA.  RNA was stored at 80°C.  
cDNA was generated using the iScript cDNA Synthesis kit (Biorad) consisting of 400ng 
RNA, 4μls iScript reaction mix, 1μl reverse transcriptase and the remaining volume, up 
to a total of 20μls, nuclease-free water.  Thermocycler was programmed at 42°C for 65 
minutes and 85°C for 5 minutes. cDNA was used instantly or stored at 4°C overnight. 
2.6.2 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
RT-PCR was performed using cDNA generated from BMPR1α KO and 
BMPR1α WT mice.  Embryo head was used as a positive control as it is known to 
express high levels of morphogens and the housekeeping gene, HPRT.  A standard 
curve using HPRT and embryo head cDNA was created in order to quantify expression 
levels.  Briefly, a series of 1 in 10 dilutions of embryo head cDNA were performed in 
order to create a standard curve using HPRT and BMP 2 primers.  Following this, 
cDNA from BMPR1α KO and WT mice was diluted 1 in 50 to allow for efficient 
extrapolation of data from the standard curve generated.  iTaq Universal SYBR Green 
Supermix (Biorad) containing DNA polymerase, dNTPs, MgCl2 and SYBR green dye 
was used at a 2X dilution.  A total reaction volume of 20μls with 10μls of SYBR Green, 
0.4μls exon-exon spanning primers to eliminate genomic DNA, 2μls cDNA and 7.6μls 
nuclease-free H2O.  Primer concentrations had previously been optimised and a 1:50 
dilution was deemed the optimal to prevent primer-dimer formation.  Dissociation 
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curves were created and analysed at each step to ensure primers anneal at specific 
temperature and time.  All primers were Qiagen quantitect and primer sequences are 
protected.  
2.7 Statistical Data Analysis 
Prior to inferential statistical tests, all data was tested for normality using the 
Shapiro Wilks and Kolmogornov-Smirnov tests.  The unpaired Student’s T-Test was 
utilised to deduce whether differences between groups were statistically significant.  
Data was considered statistically significant at the following values:  p=<0.05, p=<0.01 
and p=<0.001. 
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3. Results 
3.1 The role of Hh and BMP signalling within a heterogeneous splenic 
population 
In order to elucidate whether Hh signalling influences B cell development, cells 
isolated from BALB/c female mice were first stimulated with anti-IgM and anti-CD40 
to recapitulate antigen presence by BCR cross-linkage and co-stimulation mimicking T-
cell help, and additionally, in the presence and absence of rShh. Initially, B cells were 
analysed from within a heterogeneous splenic cell population w and the gating strategy 
used is shown in figure 3.1. 
 
 
 
 
 
 
  
 
The Developmental status of the gated B cells was then assessed by analysing 
expression of the activation marker CD23, differentiation marker CD25 and Annexin V 
for survival. A significant increase in activation, shown in figure 3.2A, was observed at 
18 hours as judged by an increase in the presence of the CD23+CD25 subset in the 
presence of 0.005μg/ml rShh (p=0.04) as previously described by Umukoro et al 
typically by 16.8% to 28.6%. 
Figure 3.1.  Gating strategy for B220+ B cells. 
             Splenic cells from BALB/c female mice were first gated using 
forward and side scatter to isolate live cells then gated on B220+ cells to isolate B 
cells.  
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This enhanced activation could be abrogated by the addition of a BMP inhibitor, 
Noggin, suggesting that both Hh and BMP signalling are required to take place for these 
early events in B cell activation and that the synergy requires BMP signalling to take 
place downstream in order to mediate its effects.  In addition, expression of CD25 was 
reduced significantly at 18 hours in the presence of 0.005μg/ml rShh (p = < 0.001) 
(Figure 3.2B) and upregulated in the presence of Noggin suggesting that Hh signalling 
may act to enhance activation but prevent further differentiation and this would appear 
to require the presence of BMP signalling to take place.  However, expression levels of 
CD25 are low at this time point (Amu et al., 2010), thus, it may be too early to observe 
draw any real conclusions about differentiation.   Co-culture of B cells with the higher 
dose of rShh, 0.05 μg/ml decreased expression of the co-stimulatory marker, CD80 in 
all subsets, all results were approaching significance (figure 3.2C)  The addition of 
Noggin to the same samples did not significantly recover development although 
expression of CD80 was increased in all.   Interestingly, in cells cultured with the lower 
dose of rShh, 0.005μg/ml there was a significant decrease in CD80 expression in the 
CD23+CD25- population (p=<0.05) whilst a simultaneous increase in the expression of 
CD80 was observed in the CD23-CD25+ subset (Figure 3.2D).  The addition of Noggin 
to the cultures containing 0.005μg/ml rShh did not affect the numbers of a CD23-
CD25+CD80+ population whilst the presence of the CD23+CD25- CD80+ population 
greatly increased although variability within samples for this particular subset was high. 
Figure 3.2. CD23 and CD25 at 18 hours within a mixed cell population. 
                  Splenocytes from BALB/c female mice were stimulated with anti-IgM 
and anti-CD40, and co-cultured for 18 hours in the presence or absence of rShh and 
Noggin.  Hh1=0.005μg/ml and Hh2=0.05μg/ml.  Scale representative of expression 
normalised to stimulated control.  Error bars represent +/- SD. N=3.  A) Dot plots 
showing cells stained for CD23 and CD25.  Left = stimulated control, mid = Hh1 and 
right = Hh1 + Noggin. B) Bar chart depicting CD23 and CD25 expression relative to 
control.  C) Histograms depicting CD80 expression within subsets gated as I) 
CD23+CD25- II) CD23+CD25+ III) CD23-CD25+. D) Bar chart showing levels of CD80 
within previously defined subsets. 
 
- 24 - 
 
CD80 would not normally be expected to be expressed at this early stage of the immune 
response and we suggest this is caused by aberrant signalling due to the inhibition of 
BMP signalling.  This aberrant signalling may then skew the development of B cells by 
upregulating the expression of CD80 prematurely in the immune response thereby 
inducing the emergence of a memory B cell population.  This data suggest that both Hh 
and BMP signalling play a role in the early activation of B cells in response to a TD 
antigenic stimulus. 
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At 40 hours subset II (CD23+CD25+) increased significantly (p=0.05) and III (CD23-
CD25+) increased and was nearing significance, in the presence of 0.005μg/ml rShh, 
from 35.6% to 57.9% and 5.6% to 13.2%, respectively (figure 3.3A and figure 3.3B).  
Identical effects were seen in cells co-cultured with 0.05μg/ml rShh, however, only the 
CD23+, subset I population, was of any significance (p=0.05). The addition of Noggin 
led to a significant decrease (p=0.01) in expression of CD25 in terms of subset II whilst 
significantly increasing CD23 expression in subset I (p=0.05) (figure 3.3B).  These 
results indicate that Hh and BMP signalling are required for B cells in order to increase 
their maturation status and consequently, reduce the levels of activated effector cells.  
Surprisingly, CD80 expression, at 40 hours, decreased in CD23-CD25+ subsets (III) in 
cultures containing 0.005μg/ml and 0.05μg/ml rShh and this was highly significant at 
p=0.01 (figure 3.3C and figure 3.3D).  Although a small increase was observed in our 
CD23+CD25+ subset (no significance), in the presence of 0.005μg/ml rShh, and 
CD23+CD25- in samples containing 0.05μg/ml rShh (no significance), variability 
between samples was high and may provide a possible reason for skewed results.  As 
CD80 is associated with a more mature B cell phenotype, primarily memory cells, we 
expected levels of CD80 to increase particularly within a CD23-CD25+ subset.  
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Analysis of induction of apoptosis in these B cells following 18 hours in culture 
revealed that the presence of rShh in cultures had little effect on the induction of 
apoptosis.  However, in the presence of Noggin, there was an apparent decrease in 
levels of Annexin-V staining indicating a pro-survival effect being mediated by the 
presence of Noggin. This would suggest that BMP signalling is inducing apoptosis in B 
cells early in the activation response, a finding that is consistent with previously 
published data whilst Hh signalling plays little role in the induction and maintenance of 
survival in at this early point in the immune response 
Consistent with data obtained by Umukoro et al, we observed that levels of 
apoptosis increased, at 40 hours, in B cells treated with rShh as compared to a 
stimulated control (Figure 3.4A and Figure 3.4B) and this level of apoptosis decreases 
with the addition of Noggin. This data suggests that Hh signalling does play a role in 
inducing apoptosis of B cells later in the immune response and that this effect is 
mediated by downstream BMP signalling. The fact that Hh signalling may induce 
apoptosis in B cells is a novel finding, and is not consistent with previously published 
data suggesting that Hh signalling delivers a pro-survival signal (Sacedon et al., 2005).  
However we believe that this finding reflects a role for Hh signalling later in the 
immune response that has not previously been investigated.  This is consistent with 
previous reports that indicate that BMP signalling may be pro-apoptotic and suggests 
that the later pro—apoptotic events induced by Hh signalling are in fact attributable to 
BMP signalling. 
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Figure 3.4.  Annexin V binding at 18 and 40 hours. 
             A) Histograms representing Annexin V binding levels, at 18 and 40 
hours post stimulus, in BALB/c female mice.  Left=Stimulated control, mid=Hh1 
and right=Hh1+Noggin.  B) Bar chart depicting levels of Annexin V binding at 18 
and 40 hours.  Data represents three experiments and error bars represent +/- SD.  
Hh1 = 0.005μg/ml and Hh2 = 0.05μg/ml. 
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Surprisingly, when analysing expression of a marker of early plasma cell 
differentiation (plasmablasts), CD138, we could not detect expression in any B-cell 
subset (data not shown).  Interestingly, a previous study noted that CD138 was 
expressed to a greater level in B220 negative cells and therefore we may not have 
observed it in our study due to the use of the expression of B220 to gate our B cell 
population.  Furthermore, problems may have been encountered due to poorly optimised 
staining concentrations, alternatively, culture times were not prolonged enough to see 
the appearance of plasmablasts in our cultures. 
3.2 The effects mediated by Hh and BMP signalling are intrinsic to B 
cells 
To determine whether observations seen earlier when analysing mixed cell 
cultures are a result of B cell intrinsic responses, splenic B cells were isolated using 
magnetic bead enrichment techniques and purified B cells were subjected to identical 
culture conditions as for previous experiments.  C57BL/6 male mice were utilised as 
our future studies using BMPR1a KO mice were on a C57BL/6 male background. 
Interestingly, figure 3.5B shows that there was a generally higher expression of CD25 
observed in B cells isolated from this strain and gender of mouse at this early time point 
in B cell activation. Thus, the presence of a CD23+ CD25+ population was significantly 
increased (p = <0.05) when compared to the control, in samples cultured for 18 hours 
with 0.005μg/ml Hh (Figure 3.5A and 3.5B).  The large presence of this CD23+CD25+ 
subset was somewhat unexpected in an early immune response. However, we suggest 
that this subset represents a heterogeneous population of B cells which display 
increased plasticity and ability to form a Follicular I and II cells, and T2-MZP cells and 
the enhanced appearance of this population may be a characteristic of the male immune 
response which is not seen to any great degree in the female immune response at this 
time-point. Alternatively, the presence of CD25+CD23- cells, which may represent a 
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mature memory cell population, decreased significantly at 18 hours in the presence of 
0.05μg/ml of rShh  (p = < 0.05) whilst the addition of Noggin led to a 2.4 fold increase 
(p = < 0.001) in the presence of this CD23-CD25+ subset.  Remarkably, there appeared 
to be no difference in the relative expression of CD25+ CD23- cells co-cultured with 
Noggin (no significance) and samples containing 0.005μg/ml rShh plus Noggin when 
compared to cells cultured with 0.005μg/ml rShh exclusively (figure 3.5B) This data 
may suggest that BMP signalling plays a more dominant role in driving the emergence 
of the CD23-CD25+ subset which we believe to be a memory type B cell whilst Hh and 
BMP signalling act synergistically to modulate the newly activated CD23+CD25- B 
cells.  Furthermore, this is consistent with studies suggesting that BMP signalling 
induces the inhibitor of differentiation family of proteins (ID) mediated by the Smad 
transcription factors resulting in a loss of the possibly more mature CD23-CD25+ B 
cells (Kersten et al., 2005).  
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Furthermore, we show that Hh signalling reduced levels of expression of the co-
stimulatory marker CD80 on all B cell subsets at 18 hours in the presence of 0.005μg/ml 
rShh (Figure 3.6A), particularly in subsets expressing CD23, and this expression was 
restored and upregulated in all subsets in the presence of Noggin, this data is consistent 
with the data obtained using the higher dose of rShh in mixed cultures and may reflect 
the fact that cells, other than B cells, have mopped up some of the rShh protein thereby 
Figure 3.5.  Expression of CD23 and CD25 at 18 hours in purified B cells. 
 
               B cells purified from the spleens of C57BL/6 male mice, stimulated as 
before, were co-cultured with rShh at varying doses.  Hh1=0.005μg/ml and 
Hh2=0.05μg/ml.  Cells were stained for CD23 and CD25 at 18 hours post stimulus.  
A) Dots plots representing changes in expression of markers.  From left to right dot 
plots represent: stimulated control, Hh1 and Hh1 + Noggin.  B) Bar chart depicting 
expression levels of CD23 and CD25.  Scale represents expression normalised to 
stimulated control.  Error bars represent +/-.  N=3. 
 
Subset I: CD23+CD25- 
Subset II: CD23+CD25+ 
Subset III: CD23-CD25+ 
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lowering the dose seen by the B cells. However, in the presence of 0.05 μg/ml rShh, 
CD80 expression was only lowered in subset I but this expression was apparently 
restored in the presence of noggin although these data are not yet significant but 
approaching significance. Thus, we show that B cell phenotypes vary in the presence of 
different doses of rShh, a characteristic that is typical of a morphogen and this may 
represent the natural events, in vivo, with the spatial arrangement of cells located at a 
particular place within a morphogen gradient thereby receiving differing dose of that 
morphogen.   
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Figure 3.6.  CD80 expression in C57BL/6 male B cells. 
      A) Histograms represent levels of CD80 expression in subsets: I) 
CD23+CD25- II) CD23+CD25+ III) CD23-CD25+, as compared to the stimulated 
control, 18 hours post stimulus.  B) Bar chart depicting relative expression of CD80 
in noted subset.  Cells cultured in varying doses of rShh: Hh1=0.005μg/ml and 
Hh2=0.05μg/ml.  Scale represents expression normalised to control.  Error bar 
represents +/- SD.  N=3. 
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3.3 BMP signalling may drive the development of a Follicular B cell 
subset 
For an effective humoral immune response to occur, B cells must undergo a 
maturation process from T2 cells to FOI in order to develop specialised germinal 
centres in preparation for affinity maturation and memory formation.  It is important 
therefore to identify how Hh and BMP signalling may influence this developmental 
process. In order to identify these particular subsets, cells were stained for markers for 
which the expression levels alter with increasing maturity. The markers selected for use 
were IgD, IgM and CD23 and their differential expression is indicated below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7.  IgD and CD23 expression at 18 hours. 
         A) Flow cytometry dot plots depicting changes in IgD and CD23 
expression in response to Hh and Hh+Noggin presence.  From left to right: Left = 
stimulated control, Mid = Hh2 and Right = Hh2 + Noggin.  Hh1=0.005μg/ml and 
Hh2=0.05μg/ml.  Subsets are I) IgD+CD23- II) IgD+CD23+ III) IgD-CD23+ B) Bar 
chart depicting expression of IgD and CD23 at 18 hours post stimulus.  B cells 
isolated for C57BL/6 male mice.  Scale represents expression normalised to 
stimulated control.  Error bars represent +/- SD.  N=3.  
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In order to determine which B cell subsets are emerging in response to the 
presence of rShh and Noggin, we analysed expression of IgD and CD23 and once again 
determined the presence of three distinct subsets of cells developing following 18 hours 
in culture. These are subset I: IgD+CD23-, subset II: IgD++CD23+ and subset III: IgD-
CD23+. Whilst still controversial, it is generally felt that IgD and CD23 expression 
increases as IgM expression decreases on a splenic B cell in response to antigen, with 
IgD and CD23 expression ultimately being switched off in the more mature class 
switched memory B cell. The data shown in Figure 3.7 indicates that in the presence of 
0.005μg/ml rShh there is an increase in the presence of the more mature subsets II and 
III at the expense of subset I and this trend is reversed in the presence of 0.005μg/ml 
rShh together with Noggin.  
We then went on to look at the expression of IgM in all three subsets. At 18 
hours post stimulus Hh signalling appears to drive down the expression of IgM in 
subsets I and II (Figure 3.8A) in the presence of 0.005μg/ml rShh, (figure 3.8A).  
Conversely, the presence of noggin in these cultures caused an upregulation of 
expression of IgM in all three subsets although the data was not yet significant. The 
significance of these findings remains to be fully understood and may just represent an 
anomaly caused by the fact that the B cells are themselves cultured in the presence of 
anti-IgM in order to become activated, and therefore the presence of IgM in the cultures 
may have affected the subsequent patterns of IgM staining.    
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Figure 3.8.  IgM expression at 18 hours. 
          A) Histogram showing expression of IgM within subsets, I) 
IgD+CD23- II) IgD+ CD23+ III) IgD-CD23+, at 18 hours post stimulus.  Cells co-
cultured with varying doses of rShh:  Hh1=0.005ug/ml and Hh2=0.05ug/ul.  B cells 
isolated from C57BL/6 male mice.  B) Bar chart depicting relative expression of 
IgM in subsets.  Scale represents expression normalised to the stimulated control.  
Error bars represents +/- SD.  N=3. 
- 37 - 
 
Pillai and Cariappa (2009) suggest that the development of an IgDmid IgMlow 
CD23high FOI subset from a T2 cell (IgMhigh IgDhigh CD23mid) is dependent on a strong 
BCR-BTK stimulus and therefore it is important to analyse the effect of Hh and BMP 
synergy on the strength of BCR-BTK signalling.  Our results suggest that Hh and, to a 
larger extent, BMP signalling regulate early BCR-dependent development of B cells.   
3.4 Dampening down of the immune response is a result of BMP 
expression. 
To elucidate whether the synergy observed between Hh and BMP signalling at 
18 hours post-stimulus also influenced the status of the immune response at 40 hours, 
expression of these same cell surface markers were analysed at 40 hours to determine 
any differences in expression. 
We observed, that at 40 hours, 0.005μg/ml rShh increases the presence of the 
IgD+CD23+ subset significantly (p=<0.005) and this decreased in the presence of 
Noggin.  These results were largely unexpected; during a later immune response we 
would expect levels of IgD and CD23 to decrease as expression of both markers have 
been shown to be inversely proportional to numbers of mature cells such as plasma and 
memory B cells.  Both markers are associated with immature or early activated B cells.  
However, as can be seen in figure 3.9B, data varied greatly from the mean and may 
provide a possible explanation for unusual results.  Furthermore, figure 3.10 shows cells 
stained for IgM displayed similar variability and non-significant data.  Nonetheless, a 
clear trend can be seen, as with 18 hours data, in that the addition of Noggin to samples 
containing rShh led to a large increase in IgM expression. 
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Figure 3.9.  IgD and CD23 expression at 40 hours. 
          A) Flow cytometry dot plots depicting changes in IgD and CD23 
expression in response to Hh and Hh+Noggin presence. Left = stimulated control, 
Mid = Hh1 and Right = Hh1 + Noggin.  Hh1=0.005μg/ml and Hh2=0.05μg/ml.  
Subsets are I) IgD+CD23- II) IgD+CD23+ III) IgD-CD23+ B) Bar chart depicting 
expression of IgD and CD23 at 18 hours post stimulus.  B cells isolated for C57BL/6 
male mice.  Scale represents expression normalised to stimulated control.  Error bars 
represent +/- SD.  N=3.  
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Figure 3.10.  IgM expression at 40 hours. 
          A) Histogram showing expression of IgM within subsets, I) 
IgD+CD23- II) IgD+ CD23+ III) IgD-CD23+, at 40 hours post stimulus. Histograms 
are: Left = stimulated control, Mid = Hh1 and Right = Hh1 + Noggin.  Cells co-
cultured with varying doses of rShh:  Hh1=0.005μg/ml and Hh2=0.05μg/ul.  B cells 
isolated from C57BL/6 male mice.  B) Bar chart depicting relative expression of 
IgM in subsets.  Scale represents expression normalised to the stimulated control.  
Error bars represents +/- SD.  N=3. 
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We observed that following 40 hours in culture, the presence of CD23+CD25+ 
and a CD23-CD25+ subsets increased when cultured in the presence of rShh (figure 
3.11) consistent with the data of Umukoro et al.  In the presence of Noggin, a 
significantly decreased presence of both subsets was observed (p=0.01).  This data 
suggests that BMP signalling is required at 40 hours to induce and maintain the effects 
previously seen in the presence of rShh signalling which was the differentiation of the 
splenic B cells to the more mature subset of B cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11.  Expression of CD23 and CD25 at 40 hours in purified B cells. 
 
               B cells purified from the spleens of C57BL/6 male mice, stimulated as 
before, were co-cultured with rShh at varying doses.  Hh1=0.005μg/ml and 
Hh2=0.05μg/ml.  Cells were stained for CD23 and CD25 at 40 hours post stimulus.  
A) Dots plots representing changes in expression of markers.  From left to right dot 
plots represent: stimulated control, Hh1 and Hh1 + Noggin.  B) Bar chart depicting 
expression levels of CD23 and CD25.  Scale represents expression normalised to 
stimulated control.  Error bars represent +/-.  N=3. 
 
Subset I: CD23+CD25- 
Subset II: CD23+CD25+ 
Subset III: CD23-CD25+ 
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Furthermore, BMP signalling promotes memory B cell induction at 40 hours and 
this can be seen in figure 3.12 in which CD80 increases significantly (p=<0.005) in a 
CD25+ population in the presence of 0.005μg/ml rShh whilst decreasing when Noggin 
is added (no significance).  These results are consistent with published works by 
Tomayko et al (2008) who found that memory B cells expressed BMPR1a at a 15-fold 
increase compared to naive cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12.  CD80 expression in C57BL/6 male B cells. 
      A) Histograms represent levels of CD80 expression in subsets: I) 
CD23+CD25- II) CD23+CD25+ III) CD23-CD25+, as compared to the stimulated 
control, 40 hours post stimulus.  B) Bar chart depicting relative expression of CD80 
in noted subset.  Cells cultured in varying doses of rShh: Hh1=0.005μg/ml and 
Hh2=0.05μg/ml.  Scale represents expression normalised to control.  Error bar 
represents +/- SD.  N=3. 
Subset I: CD23+CD25- 
Subset II: CD23+CD25+ 
Subset III: CD23-CD25+ 
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As we expected BMP signalling to regulate later immune responses we looked 
to observe differences within Annexin-V binding at 18 and 40 hours in the presence of 
both rShh and Noggin.  Figure 3.13A shows that, at 18 hours, rShh and Noggin had no 
significant effect on apoptosis and we suggest that this is a result of BMP absence.  This 
figure also shows that at 40 hours, apoptosis increases in the presence of 0.005μg/ml 
rShh compared to the control (p=<0.05) from 12.9% to 28.9%.  The addition of Noggin 
significantly abrogated apoptosis and increased survival at 40 hours (p=<0.05).  In cells 
co-cultured with Noggin alone there was no significant decrease in apoptosis, thus 
indicating that Hh signalling upregulates BMP in a later immune response in order to 
increase cell death and dampen down immune responses. 
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Figure 3.13.  Annexin V binding at 18 and 40 hours. 
             A) Histograms representing Annexin V binding levels, at 18 and 40 
hours post stimulus, in C57BL/6 male mice.  Left=Stimulated control, mid=Hh1 and 
right=Hh1+Noggin.  B) Bar chart depicting levels of Annexin V binding at 18 and 
40 hours.  Data represents three experiments and error bars represent +/- SD.  Hh1 = 
0.005μg/ml and Hh2 = 0.05μg/ml. 
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Our findings suggest that BMP at 40 hours is, firstly, upregulated by Hh and 
secondly, pro-apoptotic and verifies results from a previous study which revealed that 
BMPs differentially inhibit Ig production and B cell differentiation (Huse et al., 2011).  
Therefore, we propose that BMP negatively regulates the immune response as a result 
of Hh signalling.  
3.5. BMPR1α knockout mice display a skewed phenotype 
As Hh and BMP have been shown previously, in our study, to interact 
synergistically in both an early and late immune response we decided to analyse 
BMPR1α KO and BMPR1α WT mice in order to confirm and validate the previous 
findings observed using Noggin as an inhibitor of BMP signalling.  As expression of the 
BMPR1α receptor is an absolute requirement for effective BMP signalling to take 
place, this mouse model allows us to investigate the effect of absence of BMP signalling 
in B cells isolated from these mice as well as to determine if the observed effects 
mediated by Hh signalling require the ability of a cell to transduce a BMP signal. 
We first analysed the presence of T1, T2/FO, MZ and M (mature) cells in fresh, 
uncultured splenic B cell populations derived from the BMPR1α KO and BMPR1α WT 
mice (Figure 3.14A). Using expression of CD23 and IgD, we could observe these 
subsets in freshly isolated tissue in order to observe the effects of lack of BMP 
signalling on B cell development in vivo.  In BMPR1α KO mice a decrease was 
observed in the presence of the T2/FO cell subset when compared to the wild-type mice 
of 48.4% and 53.1%, respectively (Figure 3.14A).   
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Figure 3.14.  B cell subsets in BMPR1α KO and BMPR1α WT mice in 
fresh tissue. 
             A) Dot plot representation of B cell subsets denoted:  T1 (IgD-
CD23-), MZ (IgD+CD23-), T2/FO (IgD+CD23+) and M (IgD-CD23+).  B) 
Expression of IgD and CD23 within aforementioned subsets as compared to the WT 
control.  Error bars represent +/- SD.  Data represents two experiments.   
T1 = IgD- CD23- 
MZ = IgD+ CD23- 
T2/FO = IgD+ CD23+ 
M = IgD- CD23+ 
WT KO 
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Once the B cells had been isolated and stimulated as described previously, we 
observed that analysis of B cells isolated from BMPR1α KO mice display a higher 
representation of cells with an immature phenotype (IgD+ CD23-) when cultured in the 
presence of rShh at 18 hours relative to the control (Figure 3.15A).  This effect was not 
altered by dose.  Analysis of the presence of the more mature IgD+CD23+ subset 
revealed that there were less cells present in the B cell cultures derived from BMPR1α 
KO mice as compared to WT mice (Figure 3.15A).  Our results confirm that BMP 
signalling is required to regulate Hh-dependent B cell development, however, the 
specificities of BMP homologues remain to be revealed.  Moreover, no differences 
could be observed between the subsets isolated from BMPR1α KO and BMPR1α WT 
at 40 hours indicating that a recovery process had taken place between 18 and 40 hours. 
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Stimulated Control      Hh1 (0.005μg/ml) 
WT 
KO 
WT 
KO 
Figure 3.15.  Bar chart depicting expression of IgD and CD23 in BMPR1α 
KO and BMPR1α WT mice. 
               B cells purified from BMPR1α KO and WT mice were subject to 
identical conditions as previous experiments.  A) Dot plot representation of cell subsets, 
at 18 hours post stimulus, in female mice.  Subsets characterised as I) IgD+CD23- II) 
IgD+CD23+ III) IgD-CD23+.  B) Bar chart depicting relative expression of IgD and 
CD23 at 18 hours in female mice.  Error bars represent +/- SD.  Significance could not 
be obtained due to limited sample size as data is representative of two experiments. 
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In order to confirm whether previous results suggesting BMP’s role as a 
negative regulator of the immune response was also the case using our system, we used 
Annexin-V staining to reveal any effect of the absence of the BMPR1a gene on the 
survival of B cells following the activation stimulus in the presence and absence of rShh 
protein. We show, in figure 3.16, that BMP signalling is crucial for the observed 
induction of apoptosis in the presence of rShh protein at 40 hours, as analysis of B cells 
isolated from BMPR1α KO mice show a decrease in the Hh signalling mediated 
induction of apoptosis as judged by Annexin-V staining as compared to the wild-type 
control.  No notable difference in induction of apoptosis was detected at 18 hours.  This 
confirms our earlier studies which indicated that BMP signalling is required to mediate 
the Hh regulated termination of the immune response. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16.  Annexin V binding, at 18 and 40 hours, in BMPR1α KO 
and WT female mice. 
             Bar chart depicting levels of Annexin V binding at 18 and 40 hours.  
Data represents two experiments and error bars represent +/- SD.  Hh1 = 0.005ug/ml 
and Hh2 = 0.05ug/ml.  Significance could not be obtained due to limited sample 
size. 
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During a normal early immune response, secretion of IL-10, a regulatory 
cytokine, is repressed in order to permit efficient cell activation whilst in later stages, 
expression is increased significantly in order to inhibit hyper-activity of immune 
effector cells.  We show, in figure 3.17, that IL-10 secretion from B cells isolated from 
BMPR1α KO mice is increased considerably in the presence of a Hh signal following 
18 hours in culture relative to the wildtype control, which, conversely, drives down 
expression of IL-10.  This data suggests that the interplay between Hh and BMP during 
the B cell response to antigen is critical for the appropriate regulation of the early 
immune response creating not only an activatory environment essential for a rapid 
response to antigen but also the means by which this response may be dampened down.  
Surprisingly, analysis of IL-10 expression at 40 hours revealed that expression appeared 
identical in both WT and KO mice (not shown) mirroring the previous data obtained 
suggesting that there is some sort of recovery process happening in BMPR1a KO mice 
between 18 and 40 hours. 
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Figure 3.17.  IL-10 secretion at 18 hours in BMPR1α KO and WT mice. 
            IL-10 secretion, measured using ELISA, at 18 hours post-stimulus in 
KO and WT mice.  Error bars represent +/- SD.  Significance could not be obtained 
due to limited sample size. N=2.  
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To confirm that the Hh mediated effects on the B cell response could be 
mediated by upregulation of expression of BMP we analysed BMP expression by RT-
PCR (figure 3.18). Consistent with this hypothesis, an upregulation of expression of 
BMP-2 was observed when B cells isolated from BMPR1a WT were activated in the 
presence of Hh. Interestingly, when this same experiment was performed on B cells 
isolated from BMPR1a KO mice there was no increase in BMP-2 expression observed 
in the presence of a Hh signal indicating that a signal mediated by the presence of 
BMPR1a receptor is needed in order to upregulate expression of BMP-2 by B cells 
suggesting complex levels of regulation of these two pathways. 
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3.18. BMP-2 expression at 18 hours in BMPR1α KO and WT mice. 
BMP-2 expression measured using RT-PCR at 18 hours post stimulus.  
Results are representative of two experiments thus significance could not be 
obtained.  Error bars represent +/- SD. 
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4. Discussion 
In this study, we examined the possibility that, Hh and BMP signalling, play a 
synergistic role in the antigen-dependent development of peripheral B lymphocytes and 
this discussion will focus on our results which define a role for Hh and BMP as a 
critical regulators of TD B cell development.  It has previously been shown that Hh 
signalling delivers a positive signal for B cell proliferation, antibody secretion and 
survival and that Hh proteins were shown to be expressed by the splenic stroma and 
components of the Hh signalling pathway expressed in germinal centre B cells. 
Interestingly, these authors showed that, the expression of Smoothened, the Hh signal 
transducing receptor, is rapidly up-regulated upon GC B cell activation using anti-IgM 
and anti-CD40 (Sacedon et al., 2005).  Conversely, Huse et al (2011) revealed a 
negative regulatory role for BMP signalling in the development of human CD27+ 
memory B cells with the finding that BMP 2, 4, 6 and 7 were all capable of inhibiting Ig 
production.  With this in mind, we explored the concept of interplay between Hh and 
BMP signalling in peripheral B-cell development. 
We have shown that BMP signalling is an essential requirement for exogenously 
added rShh to give a positive activation signal at 18 hours and that inhibition of BMP 
signalling leads to skewing of development of specific B cell subsets.  Additionally, we 
show that BMP signalling is essential for dampening down the immune response at 40 
hours by increasing apoptosis and inhibiting differentiation.  Overall, our results suggest 
that, whilst BMP is a key mediator of Hh signalling, both Hh and BMP are essential 
regulators of B cell mediated immune responses. 
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4.1. Hh and BMP signalling regulate early activation and survival of 
peripheral B cells 
Hh has previously been described as a positive regulator of T cell development 
(Crompton et al., 2007; Varas et al., 2003) and a potent inducer of a Th2 transcriptional 
profile (Furmanski et al., 2013) as well as being capable of regulating B cell 
development (Sacedon et al., 2005).  Our analysis of B cells isolated from BALB/c and 
C57BL/6 mice suggest that Hh signalling drives B cell development in an accelerated 
fashion at 18 hours in response to BCR ligation and co-stimulation.  We demonstrate, 
that purified B cells cultured with rShh, display an increased level of co-expression of 
CD23 and CD25; markers associated with activation and differentiation.  Interestingly, 
in B-cells analysed within a heterogenous splenocyte population, Hh signalling 
appeared to increase activation whilst reducing differentiation in a dose-dependent 
manner.  To a certain extent this may be explained by the presence of surrounding cells 
already expressing Hh ligands, thus, exogenously added rShh is exacerbating B cell 
development.  Additionally, the possible presence of B220+ dendritic cells, in our flow 
cytometry gating strategy may have skewed results (Segura et al., 2009).  Alternatively, 
variability may be due to gender differences between the mice analysed in this study 
When Noggin was added to cultures already containing rShh to determine 
whether BMP signalling is required for Hh-mediated development we observed a 
significant skewing of B cell subsets; namely that cells appeared to increase expression 
of CD25 whilst downregulating expression of CD23. Our data suggests a novel finding 
that BMP is an absolute requirement to prevent aberrant Hh signalling in splenic B 
cells. 
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4.2. Hh and BMP synergistically induce a T2 to follicular B cell 
transition 
Knowledge of how B cell subsets develop, in response to antigen stimulation in 
the mouse, is lacking. In recent times, studies investigating human B cell subsets within 
the spleen have suggested that, dependent on the strength and type of antigenic 
stimulation, naïve resting transitional B cells develop into FOI, FOII,T2-MZP and MZ 
B cells (Pillai and Cariappa, 2009); and that these cells will go on to form plasma, 
memory or regulatory B-cells.  Interestingly, preliminary data suggest that Hh signalling 
upregulates expression of two factors involved in transmitting the BCR signal into the B 
cell, Btk and NFATC1 (Umukuro, unpublished).  Consequently, it is important that the 
factors involved in regulating the development of B cell subsets in response to differing 
levels of BCR stimulation are elucidated.  Therefore, we investigated the role of Hh and 
BMP signalling on the polarisation of specific B cell subsets. 
We found at 18 hours, in the presence of rShh, there was an increase in the 
levels of representation of a B cell population co-expressing IgD and CD23 and the 
addition of Noggin significantly decreased the presence of this population. However, in 
samples containing cells co-cultured with Noggin alone, we noted a similar decrease in 
expression within the same subset.  These results may indicate that BMP signalling 
alone is responsible for driving development of particular B cell subsets, however, we 
suggest that Hh ligands expressed by surrounding cells upregulate BMP expression in 
vivo.  
To more clearly identify B cell subsets, we examined the differential expression 
of IgM within three subsets: I) IgD+ CD23-, 2) IgD+ CD23+ and 3) IgD- CD23+.  Our 
results showed that IgM expression is reduced following Hh signalling on all subsets at 
18 hours and that this dependent on the concentration of exogenously added rShh. This 
would suggest that Hh signalling increases the maturation status of B cells from an 
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IgD++CD23+IgM+ T2/FOII cell line to an IgD+CD23+IgM- FOI subset.  Moreover, 
the presence of Noggin led to a noteworthy increase in IgM expression in all subsets 
indicating that Hh and BMP signalling interrelate to modulate the development of a T2 
to FOI cell line.  The data represented here corroborates previous data suggesting that 
the emergence of T2 and the intermediary FOII B cells, which are defined only by the 
expression of AA4.1, develop independently of antigen; and that FOII cells, upon Btk 
signalling, develop into FOI B cells (Pillai and Cariappa, 2007).  Furthermore, we show 
that Hh and BMP signalling regulate this developmental process in a dose-independent 
manner which is typical of morphogen gradient dynamics. 
Of interest is that, the BMP inhibitor, Noggin, appeared to have a greater 
inhibitory effect on BMP signalling than observed using the BMPR1α KO model which 
will be discussed below.  However, Lavery et al (2008) observed that BMP 2 and 4 
preferentially signal through BMPR1α whilst BMP 6 and 7, despite signalling 
canonically through BMPR1a, may also utilise ACVR1a and ACVR2, both canonical 
TGF-β receptors, as an alternative route.  
4.3. BMP signalling dampens down later immune responses 
A role for BMP as a negative regulator of immune responses has previously 
been described (Huse et al., 2011; Kersten et al., 2005), however, little is known 
regarding how interactions between Hh and BMP influence this process.  As the 
induction of apoptosis and inhibition of cellular differentiation has been shown to be a 
critical factor in dampening down immune responses we investigated whether a survival 
signal previously observed to be provided by Hh at 18 hours (Umukuro., 2012) becomes 
a signal for death at 40 hours as a result of BMP expression upregulation.  We found 
that at 40 hours the presence of rShh led to an increase in apoptosis and the emergence 
of a mature B cell phenotype (CD23-CD25+).  The addition of Noggin to cultures 
containing rShh led to a significant increase in cell survival and increased activation.  
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We observed increased numbers of a FOI B cell subset and suspect that these represent 
a population of cells which have the capacity to form long-lived plasma and memory 
cells (Pillai and Cariappa., 2007).   To confirm whether Hh and BMP signalling can 
influence memory cell formation we analysed the expression of CD80, a co-stimulatory 
protein and a marker of memory B cells, within subsets labelled, I) CD23+ CD25- II) 
CD23+ CD25+ III) CD23- CD25+ as we suspect that memory cells are retained within 
the CD23-CD25+ population.  We show that exogenously added rShh to samples at 40 
hours significantly increased the expression of CD80 in a CD23-CD25+ population in a 
dose-independent fashion and this effect was abrogated by the addition of Noggin in 
samples co-cultured with rShh.  As previous studies have noted that expression of 
BMPR1α is significantly upregulated in memory B cells (Huse et al., 2007; Tomayko et 
al., 2008), we suggest that these results, taken together with our data, imply that Hh and 
BMP signalling may indeed regulate memory cell formation. 
As BMP signalling has previously been documented to induce apoptosis (Huse 
et al., 2011), we investigated whether interplay between Hh and BMP influenced cell 
death at 18 and 40 hours after stimulation.  We show that in the presence of Hh 
signalling, at 40 hours, apoptosis increased significantly and, that, when Noggin was 
added to cultures containing rShh this effect is completely reversed.  There are several 
possible mechanisms by which BMP may induce cell death: the first is most likely to be 
induction of a caspase pathway (Mogi and Togari., 2003); secondly, BMP may be 
upregulating inhibitory ligands such as PD-L1 and OX-40L (Martinez et al., 2014 ) and 
lastly, BMP may increase expression of Fas ligands leading to apoptosis.  Our data, 
presented together with published works by Huse et al (2011) and Kersten et al (2005), 
which imply that BMP is a potent inducer of ID1 and ID3 whist inhibiting the 
expression of XBP-1, indicate that BMP negatively regulates the later stages of an 
immune response by regulating the degree of apoptosis. 
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4.4. BMPR1a KO mice display impaired B cell development  
We have shown, in this study, that BMP signalling is required to modulate Hh 
signalling during  B cell development using a highly specific BMP inhibitor, Noggin.  
To further validate these findings, we utilised a BMPR1a knockout model in order to 
confirm that BMP signalling is an essential requirement for Hh signalling to provide a 
positive signal to B cell development at 18 hours and a negative signal at 40 hours.  
When co-cultured with 0.005μg/ul rShh we observed that, both male and female, 
BMPR1a KO B cells displayed an impaired capacity to develop from a T2 to FOI 
subset indicating that Hh and BMP signalling are critical modulators of this transition.  
Hh signalling has previously been shown to modulate the signal strength of TCR 
signalling in mature T cells (Rowbotham et al., 2007) and preliminary data suggest that 
Hh signalling regulates the expression of key mediators of BCR signalling, thus, we 
propose that Hh and BMP signalling may interact to modulate BCR signalling in B cell 
development.  Furthermore, as the development of FOI B cells are dependent 
exclusively on BCR ligation and signalling (Pillai and Cariappa., 2007), we suggest that 
BMP is indispensable in peripheral Hh mediated B cell development.  
In order to maintain peripheral immune homeostasis, the duration and strength 
of the immune response to antigen must be tightly regulated and, although a complex 
series of events, it is well established that order is restored via two distinct mechanism: 
induction of apoptosis and secretion of IL-10.  The molecular events involved in 
regulation of these two processes within B cells, are largely unresolved but may involve 
interplay between Hh and BMP signalling.  Our findings demonstrate that Hh signalling 
regulates BMP signalling in order to induce apoptosis as, in our BMPR1α KO model, 
Hh signalling induced apoptosis is largely reduced at 40 hours in comparison to 
BMPR1α WT mice.  Our study confirms previous findings obtained at UEL and those 
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from a previous study which determined that BMP signalling negatively regulates B cell 
responses (Huse et al., 2011).  
Our study also demonstrates that Hh and BMP are regulators of IL-10 secretion 
in splenic B lymphocytes.  At 18 hours B cells isolated from BMPR1α KO mice 
displayed a substantial increase in IL-10 expression, in the presence of rShh, as 
compared to B cells isolated from BMPR1α WT mice. Although controversial, it is 
understood that IL-10 acts on cells to reduce antigen presentation via MHC molecules, 
increase expression of inhibitory ligands and inhibit pro-inflammatory cytokines.  
Therefore, our data indicates that Hh and BMP signalling are required in early responses 
to keep levels of IL-10 expression low in order to enhance the activatory environment 
required for efficient TD B cell responses. 
4.5. Hh and BMP signalling interact to induce BMP-2 expression 
 As we have shown in this study Hh and BMP interplay influences TD B cell 
development, however, whether BMP is transcriptionally activated in B cells by Hh 
signalling remained to be elucidated.  Using RT-PCR analysis in BMPR1α KO mice we 
show that, at 18 hours, B cells isolated from WT mice upregulate expression of BMP-2 
greatly in response to Hh whilst B cells isolated from BMPR1α KO mice exhibit an 
impaired capacity for BMP-2 expression as no visible expression could be 
distinguished.  This would suggest that Hh signalling and signalling through BMPR1a 
is required in order to upregulate BMP-2 in response to antigenic stimulation making 
the interplay between these two molecules far more complex than first expected.  
Although some studies have implied that Gli and Smad proteins may interact at the 
transcriptional level and this may go some way to explaining our phenomenon (Nye et 
al., 2014). In addition, RT-PCR analysis of BMP-4 expression showed no notable 
difference between samples stimulated with anti-IgM/anti-CD40 and Hh (Not shown).  
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Therefore, we show that BMP-2, specifically, regulates early immune responses in a 
Hh-driven mode.  
For the first time, our data demonstrates that BMP is a critical regulator of Hh 
signalling in B cells and that both Hh and BMP signalling is essential in order for 
splenic B cells to develop in response to antigenic stimulation.  The role of Hh and 
BMP on peripheral B cell development is summarised in figure 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 59 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 60 - 
 
4.6. Future work 
B-cell driven adaptive immune responses require an intricate balance between 
activation and termination to prevent unnecessary or inadequate host tissue damage.  
Currently, research into the regulation of B cell development in the mouse is limited 
with the majority of studies focussing on the role of B cells in disease, as such 
inadequate definitive research defining the normal splenic B cell developmental process 
exists.  Splenic B cell development is a multifaceted process involving complex 
interactions between many secreted factors including Hh and BMP and future studies 
will need to determine which specific BMPs are responsible for the regulation of Hh-
driven responses.  Additionally, it is highly likely that BMPs themselves interact to 
modulate Hh signalling thus closing the circle of regulation.  BMP expression is 
regulated by a number of secreted proteins within the extracellular space including 
Noggin and Twisted Gastrulation, thus, the interplay between regulators of BMP in 
directing B cell development also remains to be properly characterised.  Furthermore, it 
is a possibility that Hh and BMP signalling pathways interact or converge at key 
checkpoints in B cell development and this is likely to play a crucial role in B cell 
development.  Understanding the mechanisms that contribute to peripheral B cell 
development will influence future studies and may provide scope for novel therapeutic 
targets in B cell mediated immune disorders and malignancies. 
  
5. Concluding remarks 
In conclusion, our data revealed a novel role for BMP, as a modulator, of Hh 
signalling in the activation of splenic B cells in response to TD antigenic stimulation.  
Use of a highly specific BMP inhibitor, Noggin, results in a skewed phenotype in an 
early immune response.  Moreover, Hh and BMP signalling together generate an 
- 61 - 
 
environment for activation by inhibiting IL-10 secretion at 18 hours.  We show that loss 
of BMPR1α leads to an anti-apoptotic and activated response at 40 hours post 
stimulation. Thus, we propose that Hh and BMP interplay is an essential requirement 
for Hh driven B cell development. 
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